Thermo Fisher, Danaher among firms competing for KKR's LGC Group - Bloomberg

医疗设备制造商赛默飞世尔有意竞购KKR & Co旗下LGC Group

2019-09-09 14:00:00 YAHOO!FINANCE

本文共536个字,阅读需2分钟

Medical device makers Thermo Fisher Scientific Inc and Danaher Corp have expressed interest in KKR & Co's potential sale of its scientific measurement and testing company LGC Group, Bloomberg reported on Friday. The sale of LGC could get the private equity firm more than $2 billion, including debt, the report said, citing people familiar with the matter. Blackstone Group Inc, Carlyle Group LP, CVC Capital Partners and EQT Partners are also weighing offers for the business, according to the report, which added that the talks are at an early stage. (https://bloom.bg/2lXEMY9) LGC, previously called Laboratory of the Government Chemist, generates annual earnings before interest, taxes, depreciation and amortization of about $150 million after factoring in its recent acquisitions, the report said. A KKR spokeswoman and EQT Partners declined to comment to a Reuters request. Blackstone, Carlyle and CVC Capital were not immediately respond to a request for comment. Thermo Fisher and Danaher too did not immediately respond.
彭博( Bloomberg )上周五报道,医疗设备制造商 Thermo Fisher Scientific Inc .和丹纳赫公司( Danaher Corp )表示有意出售 KKR & Co 旗下的科学测量和测试公司 LGC Group 。 报告援引知情人士的话说,出售 LGC 可能会使这家私募股权公司获得超过20亿美元的资金,包括债务。 报告称,黑石集团( Blackstone Group Inc .)、凯雷集团( Carlyle Group LP )、 CVC Capital Partners 和 EQT Partners 也在考虑收购要约。报告补充称,谈判还处于初期阶段。( https://bloom.bg/2lXEMY9) 报告称, LGC 之前被称为政府化验师实验室( Laborator of Government Chemists ),在计入最近的收购后,每年产生约1.5亿美元的息税折旧及摊销前利润。 KKR 发言人和 EQTPartners 拒绝对路透社的请求置评。黑石( Blackstone )、凯雷( Carlyle )和 CVC Capital 没有立即回应置评请求。Thermo Fisher 和 Danaher 也没有立即做出反应。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文